A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

May 31, 2013

Conditions
Adult Male Hypogonadism
Interventions
DRUG

Testosterone gel (FE 999303)

Trial Locations (19)

Unknown

Medical Affiliated Research Cente, Huntsville

California Professional Research, Newport Beach

San Diego Sexual Medicine, San Diego

Connecticut Clinical Research, Middlebury

South Florida Medical Research, Aventura

Michigan Institute of Urology, Saint Clair Shores

Quality Clinical Research, Omaha

Premier Urology Associates, Lawrenceville

University Urology, New York

Premier Medical Group of the Hudson Valley, Poughkeepsie

PMG Research of Wilmington, Winston-Salem

Tristate Urologic Services, Cincinnati

Omega Medical Research, Warwick

Coastal Carolina Research Center, Mt. Pleasant

Carolina Urologic Research Center, Myrtle Beach

Clinical Research Associates, Nashville

Urology Clinics of North Texas, Dallas

St. Joseph's Healthcare, London

Private Practice and Clinical Research, North Bay

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY